Cite
HARVARD Citation
Iwamoto, N. et al. (2022). A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics. Analyst. 147 (19), pp. 4275-4284. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Iwamoto, N. et al. (2022). A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics. Analyst. 147 (19), pp. 4275-4284. [Online].